Chemoinformaics analysis of Isobutyric acid, pentadecyl ester
| Molecular Weight | 298.511 | nRot | 15 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 1 |
| Exact Molecular Weight | 298.287 | nRing | 0 |
| Solubility: LogS | -6.944 | nHRing | 0 |
| Solubility: LogP | 7.858 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 58.6721 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.263 |
| Synth | 1.925 |
| Natural Product Likeliness | 0.27 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.798 |
| MDCK | 0.0000143 |
| BBB | 0.16 |
| PPB | 0.976338 |
| VDSS | 1.933 |
| FU | 0.0189251 |
| CYP1A2-inh | 0.232 |
| CYP1A2-sub | 0.197 |
| CYP2c19-inh | 0.424 |
| CYP2c19-sub | 0.087 |
| CYP2c9-inh | 0.171 |
| CYP2c9-sub | 0.913 |
| CYP2d6-inh | 0.171 |
| CYP2d6-sub | 0.062 |
| CYP3a4-inh | 0.302 |
| CYP3a4-sub | 0.093 |
| CL | 4.252 |
| T12 | 0.109 |
| hERG | 0.274 |
| Ames | 0.004 |
| ROA | 0.035 |
| SkinSen | 0.942 |
| Carcinogencity | 0.056 |
| EI | 0.981 |
| Respiratory | 0.771 |
| NR-Aromatase | 0.093 |
| Antiviral | Yes |
| Prediction | 0.603984 |